The store will not work correctly when cookies are disabled.
2-(hydroxymethyl)-1-(4-methylbenzenesulfonyl)-1H-indole-3-carboxylic acid
ID: ALA5282200
Max Phase: Preclinical
Molecular Formula: C17H15NO5S
Molecular Weight: 345.38
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(S(=O)(=O)n2c(CO)c(C(=O)O)c3ccccc32)cc1
Standard InChI: InChI=1S/C17H15NO5S/c1-11-6-8-12(9-7-11)24(22,23)18-14-5-3-2-4-13(14)16(17(20)21)15(18)10-19/h2-9,19H,10H2,1H3,(H,20,21)
Standard InChI Key: ZCQLIUTYPMTSHL-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
-1.9636 1.3360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9756 0.5111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2674 0.0883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5471 0.4903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2334 0.2240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4769 -0.5639 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.0837 -1.1688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7280 0.8843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5528 0.8723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2529 1.5586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5192 2.3393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3285 2.4990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0235 2.9602 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5351 1.3151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2433 1.7380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2739 -0.3504 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8895 -1.2785 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9756 1.5807 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.1593 -1.9573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4003 -2.5602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2051 -2.3767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4489 -1.5928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8918 -0.9848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7886 -2.9602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
8 5 1 0
8 9 1 0
10 8 2 0
10 11 1 0
11 12 1 0
11 13 2 0
14 10 1 0
4 14 2 0
14 15 1 0
15 1 2 0
6 16 2 0
6 17 2 0
9 18 1 0
19 7 2 0
20 19 1 0
21 20 2 0
22 21 1 0
23 22 2 0
7 23 1 0
21 24 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 345.38 | Molecular Weight (Monoisotopic): 345.0671 | AlogP: 2.38 | #Rotatable Bonds: 4 |
Polar Surface Area: 96.60 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.44 | CX Basic pKa: ┄ | CX LogP: 2.33 | CX LogD: -1.07 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.76 | Np Likeness Score: -0.74 |
References
1. Danilenko AV, Volov AN, Volov NA, Platonova YB, Savilov SV.. (2023) Design, synthesis and biological evaluation of novel indole-3-carboxylic acid derivatives with antihypertensive activity., 90 [PMID:37236375] [10.1016/j.bmcl.2023.129349] |